NEWS - First results for Phase IIa data of UCB's lacosamide for treatment of fibromyalgia

[Guest guest]

First Results For Phase IIa Data Of UCB's Lacosamide For Treatment Of

Fibromyalgia

MedicalNewsToday.com

Article Date: 25 Jun 2008 - 4:00 PDT

UCB announced headline results based on first-line analyses of its

Phase IIa clinical trial with lacosamide to treat fibromyalgia

syndrome. The initial results from this proof of concept study showed

activity of lacosamide in fibromyalgia syndrome but require further

analysis. A decision to start Phase IIb will be made by the end of the

year. This lacosamide trial was randomized, placebo-controlled and

double-blind to assess efficacy and safety of 400mg/day lacosamide

tablets in patients suffering from signs and symptoms associated with

fibromyalgia syndrome (FMS). This trial was designed to establish a

signal to provide justification for further clinical development of

lacosamide in FMS.

***************************************************************

Read the entire article here:

http://www.medicalnewstoday.com/articles/112691.php

--

Not an MD